Sands Capital Alternatives, LLC

ARLINGTON, VA · CIK 1846444 · 13F filing filed 2026-08-13

SEC-registered investment adviser since 2011 · limited liability company

Assets managed$5.4bn
Staff182 · 66 in investment roles
Main clients (by assets)Private funds 97%, Pension plans 3%
Private funds34 · $3.7bn gross assets
Websitesandscapital.com
Form ADV · 2026-07-28SEC adviser record

Legal entitySANDS CAPITAL ALTERNATIVES, LLC (US)

$613.5m reported value +45.7% vs Q1 2026

24positions

80.8%in top 10

3 new 10 added 2 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	ALAMAR BIOSCIENCES INC COMMON STOCK ALMR	ALMR	4,230,926	$114.6m18.68%	18.68%	New
2	NU HLDGS LTD ORD SHS CL A NU	NU	7,094,952	$94.8m15.45%	15.45%	Added +557.2k	+557,183 8.5%
3	KLAVIYO INC COM SER A KVYO	KVYO	3,928,146	$59.3m9.67%	9.67%	Added +278.5k	+278,468 7.6%
4	BETA BIONICS INC COM BBNX	BBNX	3,708,043	$58.1m9.47%	9.47%	Unchanged
5	SPYGLASS PHARMA INC COM SHS SGP	SGP	2,500,012	$55.7m9.07%	9.07%	Unchanged
6	INHIBIKASE THERAPEUTICS INC COM NEW IKT	IKT	13,018,965	$26.4m4.31%	4.31%	Unchanged
7	DOORDASH INC CL A DASH	DASH	127,562	$23.5m3.84%	3.84%	Added +16.3k	+16,331 14.7%
8	COUPANG INC CL A CPNG	CPNG	1,329,314	$23.1m3.76%	3.76%	Added +317.2k	+317,223 31.3%
9	DATADOG INC CL A COM DDOG	DDOG	80,851	$21.1m3.43%	3.43%	Reduced -4.9k	-4,942 -5.8%
10	BIOAGE LABS INC COM BIOA	BIOA	786,353	$19.3m3.14%	3.14%	Unchanged
11	10X GENOMICS INC CL A COM TXG	TXG	481,770	$18.5m3.01%	3.01%	Unchanged
12	SAMSARA INC COM CL A IOT	IOT	515,658	$16.7m2.73%	2.73%	Reduced -44.6k	-44,629 -8.0%
13	ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX	ODTX	875,000	$16.4m2.67%	2.67%	New
14	TOAST INC CL A TOST	TOST	364,879	$10.2m1.65%	1.65%	Added +63.2k	+63,232 21.0%
15	ACUMEN PHARMACEUTICALS INC COM ABOS	ABOS	3,720,105	$9.9m1.62%	1.62%	Unchanged
16	SERVICETITAN INC SHS CL A TTAN	TTAN	108,545	$7.7m1.25%	1.25%	Added +18.7k	+18,689 20.8%
17	CEREBRAS SYSTEMS INC COM CL A CBRS	CBRS	32,825	$7.3m1.18%	1.18%	New
18	SNOWFLAKE INC CL A SNOW	SNOW	24,498	$6.2m1.02%	1.02%	Added +4.2k	+4,245 21.0%
19	MONDAY COM LTD SHS MNDY	MNDY	81,982	$5.9m0.97%	0.97%	Added +14.1k	+14,114 20.8%
20	TARSUS PHARMACEUTICALS INC COM TARS	TARS	85,000	$5.3m0.87%	0.87%	Unchanged
21	TAYSHA GENE THERAPIES INC COM SHS TSHA	TSHA	724,873	$4.9m0.80%	0.80%	Unchanged
22	CANDEL THERAPEUTICS INC COM CADL	CADL	405,837	$4.2m0.68%	0.68%	Unchanged
23	ACRIVON THERAPEUTICS INC COMMON STOCK ACRV	ACRV	2,289,271	$4.1m0.66%	0.66%	Added +166.7k	+166,666 7.8%
24	FIGMA INC CLASS A COM STK FIG	FIG	22,165	$401.0k0.07%	0.07%	Added +3.9k	+3,879 21.2%

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13	ABOS	5.6%≈ $9.1m		13G	2025-08-13